A detailed history of Sbi Securities Co., Ltd. transactions in Personalis, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 66 shares of PSNL stock, worth $632. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66
Previous 209 68.42%
Holding current value
$632
Previous $734,000 41.01%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

SELL
$3.0 - $6.57 $429 - $939
-143 Reduced 68.42%
66 $433,000
Q1 2025

May 01, 2025

BUY
$3.51 - $6.64 $459 - $869
131 Added 167.95%
209 $734,000
Q4 2024

Feb 05, 2025

BUY
$3.38 - $6.26 $263 - $488
78 New
78 $451,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $440M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.